Evusheld doses go unused, despite demand in vulnerable patients
Mar 08, 2022
Fully 80% of the drug’s supply is languishing on shelves while physicians remain uninformed or uncertain about the drug and its guidance, a new report finds.
CNAs cite staffing shortage as biggest on-the-job challenge: survey
By
Kimberly Bonvissuto
Mar 07, 2022
“This survey reveals not only that CNAs are burned out and frustrated, but also that the CNA staffing shortage itself is posing the greatest challenge to their work right now,” NAHCA CEO Lori Porter...
Clinical briefs for Tuesday, March 8
By
Alicia Lasek
Mar 08, 2022
Patients weigh risks of taking new Alzheimer’s drug Aduhelm … Palliative care services vary by U.S. region for these groups … The puzzling virus that affects almost everyone: Epstein-Barr …...
AMDA calls for public list of nursing home industry’s ‘underutilized’ and ‘invisible’ medical...
By
Alicia Lasek
Mar 07, 2022
President Biden’s call for nursing home reform must extend to the industry’s clinical leadership as well, a top clinician advocate contends. A public directory would be a step toward transparency...
Small building proponents embrace Biden’s nursing home overhaul plan
By
Alicia Lasek
Mar 07, 2022
The proposed phase-out of multiple-occupancy rooms is crucial to helping prevent uncontrolled infectious disease outbreaks, the Green House Project says.
Stable use of antipsychotics in long-term care during pandemic ‘reassuring’: study
By
Kimberly Bonvissuto
Mar 07, 2022
The use of antipsychotics and pain medications in assisted living and nursing home residents was relatively unchanged early in the pandemic. New residents were more likely to get certain drugs, however.
Clinical briefs for Monday, March 7
By
Alicia Lasek
Mar 07, 2022
Almost a third of recovered COVID-19 patients report symptoms lasting 6 to 12 months … States saddled with unused COVID-19 vaccines; CDC advises docs to discard doses … Typical post-acute care user...
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...
Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.
More U.S. adults using melatonin as sleep aid despite lack of evidence
Mar 04, 2022
Use of the supplement melatonin by U.S. adults has more than quintupled between 1999 and 2018, a new study has found.